| Methanesulfonamide, N-[2-[[5-chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-, hydrochloride (1:1) |
化合物CZC-54252 HYDROCHLORIDE |
1784253-05-9 |
| HEMICHOLINIUM-3 |
半胆碱基-3 |
312-45-8 |
| 1-Hexanol, 2-[(2-amino-7-fluoropyrido[3,2-d]pyrimidin-4-yl)amino]-2-methyl-, (2R)- |
SELGANTOLIMOD |
2004677-13-6 |
| Methanone, [(3R)-3-fluoro-1-pyrrolidinyl][6-[[5-(trifluoromethyl)-2-pyridinyl]oxy]-2-quinolinyl]- |
ABBV-318 |
1802848-94-7 |
| 1H-Indole-7-carboxamide, 4-[(3S)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl]- |
ELSUBRUTINIB |
1643570-24-4 |
| EPZ011969 |
化合物EPZ011989 |
1598383-40-4 |
| BLU 9931 |
BLU 9931 |
1538604-68-0 |
| Enasidenib |
恩西地平 |
1446502-11-9 |
| JW 480 |
JW 480 |
1354359-53-7 |
| S)-1-(sec-butyl)-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-3-Methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxaMide |
GSK126 |
1346574-57-9 |
| GSK-2256098 |
GSK-2256098 |
1224887-10-8 |
| TCS 2210 |
TCS 2210 |
1201916-31-5 |
| 2-(4,5-DIHYDROIMIDAZOL-2-YL)ISOQUINOLINE HYDROCHLORIDE |
化合物BU 226 HYDROCHLORIDE |
1186195-56-1 |
| MK-2206 2HCl |
MK-2206 2HCl |
1032350-13-2 |
| PF-04691502 |
2-氨基-8-[反式-4-(2-羟基乙氧基)环己基]-6-(6-甲氧基-3-吡啶基)-4-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮 |
1013101-36-4 |
| VRT752271 |
4-[5-氯-2-[(1-甲基乙基)氨基]-4-吡啶基]-N-[(1S)-1-(3-氯苯基)-2-羟基乙基]-1H-吡咯-2-甲酰胺 |
869886-67-9 |
| 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-triMethyl-, (6S)- |
(6S)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]噻唑并[4,3-A][1,4]二氮杂卓-6-乙酸 |
202592-23-2 |
| LONAFARNIB |
洛那法尼 |
193275-84-2 |
| CO-1686 |
CO1686 |
1374640-70-6 |
| ABI-H0731 |
ABI-H0731 |
2090064-66-5 |
